Syra Health Corp.
SYRA
$0.097
-$0.001-1.02%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.19% | 6.02% | 13.62% | 42.50% | 101.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.19% | 6.02% | 13.62% | 42.50% | 101.15% |
| Cost of Revenue | -26.33% | -12.67% | 31.01% | 54.36% | 90.31% |
| Gross Profit | 115.11% | 96.53% | -21.75% | 20.52% | 173.01% |
| SG&A Expenses | -46.00% | -29.93% | -27.43% | 17.13% | 60.60% |
| Depreciation & Amortization | -65.52% | -45.60% | -41.13% | 105.65% | 41.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -40.20% | -27.07% | -8.86% | 39.38% | 90.56% |
| Operating Income | 95.45% | 67.22% | 49.13% | -25.04% | -77.35% |
| Income Before Tax | 95.43% | 67.36% | 49.32% | -17.80% | -73.18% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 95.43% | 67.36% | 49.32% | -17.80% | -73.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 95.43% | 67.36% | 49.32% | -17.80% | -73.18% |
| EBIT | 95.45% | 67.22% | 49.13% | -25.04% | -77.35% |
| EBITDA | 95.83% | 67.41% | 49.23% | -21.98% | -77.92% |
| EPS Basic | 97.48% | 81.69% | 67.16% | 29.27% | -14.89% |
| Normalized Basic EPS | 97.49% | 81.68% | 67.21% | 29.33% | -14.83% |
| EPS Diluted | 97.48% | 81.69% | 67.16% | 29.27% | -14.89% |
| Normalized Diluted EPS | 97.49% | 81.68% | 67.21% | 29.33% | -14.83% |
| Average Basic Shares Outstanding | 80.83% | 78.39% | 54.44% | 66.61% | 50.78% |
| Average Diluted Shares Outstanding | 80.83% | 78.39% | 54.44% | 66.61% | 50.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |